These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 8302606)
1. Insertional activation of mevalonate kinase by hepatitis B virus DNA in a human hepatoma cell line. Graef E; Caselmann WH; Wells J; Koshy R Oncogene; 1994 Jan; 9(1):81-7. PubMed ID: 8302606 [TBL] [Abstract][Full Text] [Related]
2. Enzymatic properties of overexpressed HBV-mevalonate kinase fusion proteins and mevalonate kinase proteins in the human hepatoma cell line PLC/PRF/5. Graef E; Caselmann WH; Hofschneider PH; Koshy R Virology; 1995 Apr; 208(2):696-703. PubMed ID: 7747441 [TBL] [Abstract][Full Text] [Related]
3. Hepatitis B virus as an insertional mutagene in a human hepatocellular carcinoma. Dejean A; de Thé H Mol Biol Med; 1990 Jun; 7(3):213-22. PubMed ID: 2170809 [TBL] [Abstract][Full Text] [Related]
4. Expression profile of nine novel genes differentially expressed in hepatitis B virus-associated hepatocellular carcinomas. Kim MY; Park E; Park JH; Park DH; Moon WS; Cho BH; Shin HS; Kim DG Oncogene; 2001 Jul; 20(33):4568-75. PubMed ID: 11494152 [TBL] [Abstract][Full Text] [Related]
5. Modification of cyclin A expression by hepatitis B virus DNA integration in a hepatocellular carcinoma. Wang J; Zindy F; Chenivesse X; Lamas E; Henglein B; Bréchot C Oncogene; 1992 Aug; 7(8):1653-6. PubMed ID: 1321406 [TBL] [Abstract][Full Text] [Related]
6. HBV DNA integration and HBV-transcript expression in non-B, non-C hepatocellular carcinoma in Japan. Tamori A; Nishiguchi S; Kubo S; Narimatsu T; Habu D; Takeda T; Hirohashi K; Shiomi S J Med Virol; 2003 Dec; 71(4):492-8. PubMed ID: 14556260 [TBL] [Abstract][Full Text] [Related]
7. [Identification of hepatitis B virus integration sites in hepatocellular carcinoma tissues from patients with chronic hepatitis B]. Tu H; Gao HF; Ma GH; Liu Y Zhonghua Yi Xue Za Zhi; 2006 May; 86(18):1249-52. PubMed ID: 16796883 [TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus-related insertional mutagenesis in chronic hepatitis B patients as an early drastic genetic change leading to hepatocarcinogenesis. Minami M; Daimon Y; Mori K; Takashima H; Nakajima T; Itoh Y; Okanoue T Oncogene; 2005 Jun; 24(27):4340-8. PubMed ID: 15806150 [TBL] [Abstract][Full Text] [Related]
9. [Hepatitis B virus and hepatocellular carcinoma]. Tiollais P; Dejean A; Buendia MA Ann Gastroenterol Hepatol (Paris); 1991 Nov; 27(6):288-92. PubMed ID: 1772242 [TBL] [Abstract][Full Text] [Related]
10. Integrated hepatitis B virus X and 3' truncated preS/S sequences derived from human hepatomas encode functionally active transactivators. Schlüter V; Meyer M; Hofschneider PH; Koshy R; Caselmann WH Oncogene; 1994 Nov; 9(11):3335-44. PubMed ID: 7936659 [TBL] [Abstract][Full Text] [Related]
11. HBV integrants of hepatocellular carcinoma cell lines contain an active enhancer. Shamay M; Agami R; Shaul Y Oncogene; 2001 Oct; 20(47):6811-9. PubMed ID: 11687960 [TBL] [Abstract][Full Text] [Related]
12. Characterization of the role of individual protein binding motifs within the hepatitis B virus enhancer I on X promoter activity using linker scanning mutagenesis. Gustin K; Shapiro M; Lee W; Burk RD Virology; 1993 Apr; 193(2):653-60. PubMed ID: 8384750 [TBL] [Abstract][Full Text] [Related]
13. [Hepatitis B virus and hepatocellular carcinoma]. Tiollais P; Dejean A; Buendia MA Bull Acad Natl Med; 1991 Feb; 175(2):263-71; discussion 271-2. PubMed ID: 1650625 [TBL] [Abstract][Full Text] [Related]
14. Integrations of the hepatitis B virus (HBV) and human papillomavirus (HPV) into the human telomerase reverse transcriptase (hTERT) gene in liver and cervical cancers. Ferber MJ; Montoya DP; Yu C; Aderca I; McGee A; Thorland EC; Nagorney DM; Gostout BS; Burgart LJ; Boix L; Bruix J; McMahon BJ; Cheung TH; Chung TK; Wong YF; Smith DI; Roberts LR Oncogene; 2003 Jun; 22(24):3813-20. PubMed ID: 12802289 [TBL] [Abstract][Full Text] [Related]
15. [Gene expression of hepatitis viruses in the liver and hepatocarcinogenesis]. Koike K Hum Cell; 1992 Jun; 5(2):150-9. PubMed ID: 1327091 [TBL] [Abstract][Full Text] [Related]
16. The hepatitis B virus X protein up-regulates tumor necrosis factor alpha gene expression in hepatocytes. Lara-Pezzi E; Majano PL; Gómez-Gonzalo M; García-Monzón C; Moreno-Otero R; Levrero M; López-Cabrera M Hepatology; 1998 Oct; 28(4):1013-21. PubMed ID: 9755238 [TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of a prevalent hepatitis B virus X protein mutant in Taiwanese patients with hepatocellular carcinoma. Yeh CT; Shen CH; Tai DI; Chu CM; Liaw YF Oncogene; 2000 Nov; 19(46):5213-20. PubMed ID: 11077437 [TBL] [Abstract][Full Text] [Related]
18. Stable HepG2- and Huh7-based human hepatoma cell lines for efficient regulated expression of infectious hepatitis B virus. Sun D; Nassal M J Hepatol; 2006 Nov; 45(5):636-45. PubMed ID: 16935386 [TBL] [Abstract][Full Text] [Related]
19. Transactivation of cellular promoters by an integrated hepatitis B virus DNA. Yamamoto S; Nakatake H; Kawamoto S; Takimoto M; Koshy R; Matsubara K Biochem Biophys Res Commun; 1993 Apr; 192(1):111-8. PubMed ID: 8476412 [TBL] [Abstract][Full Text] [Related]
20. DDX3, a DEAD box RNA helicase, is deregulated in hepatitis virus-associated hepatocellular carcinoma and is involved in cell growth control. Chang PC; Chi CW; Chau GY; Li FY; Tsai YH; Wu JC; Wu Lee YH Oncogene; 2006 Mar; 25(14):1991-2003. PubMed ID: 16301996 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]